Search Results

Russia has manufactured 15 RITM-200 reactors

Alexey Likhachev, CEO of Rosatom, presented plans for constructing nuclear power plants of various capacities at a nuclear energy development meeting, with small-capacity nuclear power systems being one of the key topics. According to the presentation, Russia has manufactured 15 RITM-200 reactors to date, with another 13 under construction. The RITM-200 is Russia's new-generation marine reactor, primarily used in Project 22220 nuclear-powered icebreakers. The most recent reactor equipment has been delivered to the nuclear-powered icebreaker Leningrad. Rosatom is developing small nuclear power plant solutions based on the RITM-200, covering both land-based and marine applications...

2026-08-25

Rosatom to Conduct Site Surveys for Myanmar Small Nuclear Power Plant in 2027

Russia and Myanmar are advancing the implementation of a small nuclear power plant project. Russian Prime Minister Mikhail Mishustin stated during a meeting with visiting Myanmar President Min Aung Hlaing on August 18 that the project will promote deeper cooperation between the two countries in basic research, applied sciences, and related fields. Rosatom CEO Alexey Likhachev said the company expects to sign a preliminary engineering survey contract by the end of this year and plans to commence site construction in 2027. He also noted that the project timeline depends not only on the Russian side but also on...

2026-08-25

Akiram Therapeutics and ITM Sign Lutetium-177 Supply Agreement to Support Radiopharmaceutical Development for Solid Tumors

Akiram Therapeutics, a Swedish clinical-stage biotechnology company, and ITM Isotope Technologies Munich SE, a German radiopharmaceutical biotechnology company, recently announced the signing of a supply agreement. Under the agreement, ITM will supply no-carrier-added lutetium-177 (nca Lu-177) to Akiram to support the clinical development of its targeted antibody-radionuclide conjugate, 177Lu-AKIR001 (AKIR001). AKIR001 is Akiram's lead radiopharmaceutical candidate, currently being investigated in clinical studies for the treatment of CD44v6-expressing solid tumors. The candidate combines the therapeutic radioisotope nca Lu-177 with a proprietary antibody targeting CD44v6. CD...

2026-08-20

Nuclear-powered icebreaker "Leningrad" completes installation of two RITM-200 reactors

United Shipbuilding Corporation (USC) announced that Baltic Shipyard has completed the installation of two RITM-200 nuclear reactors on the Project 22220 nuclear-powered icebreaker "Leningrad". The "Leningrad" is the sixth vessel in the Project 22220 nuclear-powered icebreaker series. The vessel is being built by Baltic Shipyard under an order from Rosatom, and its keel-laying ceremony was held on January 26, 2024. Project 22220 nuclear-powered icebreakers are primarily designed to ensure year-round navigation in the western Arctic waters of Russia. Equipped with nuclear propulsion systems, these vessels can perform icebreaking escort and fairway maintenance missions under complex ice conditions.

2026-08-18

Russia Plans to Build Small Nuclear Power Plant in Kyrgyzstan, Land-Based Icebreaker Reactor in Focus

Rosatom's plan to promote the construction of a small nuclear power plant in Kyrgyzstan is centered around discussions on the RITM-200N reactor design. With a power output of approximately 55 MW, this reactor is the land-based version of the RITM-200 reactor used in Russia's new generation of nuclear-powered icebreakers. Several Russian nuclear-powered icebreakers currently operate on the same technological platform, which serves as the primary basis for Russia to demonstrate its maturity and reliability. The project first entered public discussion in January 2022. At that time, Kyrgyzstan's energy authorities stated that if a nuclear power plant were to be built, its installed capacity should be no less than 300 MW, reflecting the country's practical concerns over power shortages and energy security...

2026-08-14

ITM Receives Complete Response Letter from FDA for ¹⁷⁷Lu-edotreotide New Drug Application

Radiopharmaceutical biotechnology company ITM Isotope Technologies Munich SE (ITM) announced on August 10 that it had received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) on August 7, 2026, regarding the New Drug Application (NDA) for its investigational drug ¹⁷⁷Lu-edotreotide (ITM-11). The drug is intended for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

2026-08-11

Rosatom Says Small Nuclear Power Development Requires Regulatory Reform

Rosatom Director General Alexey Likhachev said on July 5 that if Russia hopes to maintain its global leadership in the small nuclear power market, nuclear regulations and standards also need to keep pace with technological changes, particularly by revisiting the licensing and approval process for small nuclear power plants. In an article published in the Rosatom Corporate Newspaper, Likhachev stated that small nuclear power plants are expected to become a significant new form of energy in the coming decades, but their deployment still faces considerable regulatory challenges. Due to the relative novelty of such facilities to regulators, approval approaches tend to be cautious. He believes that accelerating the licensing and construction process while ensuring safety has become a task of national importance.

2026-07-06

Russia Completes Manufacturing of Second RITM-200 Reactor Unit for Leningrad Nuclear-Powered Icebreaker

On July 29, Rosatom's ZiO-Podolsk Mechanical Plant in the Moscow Region completed the manufacturing of the second RITM-200 reactor unit for the Leningrad nuclear-powered icebreaker. With this, the manufacturing of all major equipment for the reactor compartment of this under-construction 22220-type universal nuclear-powered icebreaker has been fully completed. The Leningrad nuclear-powered icebreaker began construction in January 2024. The naming of the vessel is linked to the 80th anniversary of the lifting of the Siege of Leningrad, with veterans and survivors of the siege proposing that this new-generation nuclear-powered icebreaker be named Leningrad. Following Rosatom's tradition of naming reactor units, the two completed reactor units of the Leningrad have been named "Iskra" and "Grom," commemorating the operations that broke and ultimately lifted the Siege of Leningrad between 1943 and 1944.

2026-07-30